Bone Biologics Corp - BBLG

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2026 · Compare: Q4 2025
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Tower Research Capital LLC (TRC) History Added to 4,126 4 0.0% 0.0% 1 +747 22.11% Q1 2026 May 15, 2026
DRW Securities, LLC History Closed out 0 0 0.0% -23,576 -100.0% Q1 2026 May 13, 2026
TWO SIGMA INVESTMENTS, LP History Closed out 0 0 0.0% -11,083 -100.0% Q1 2026 May 15, 2026
CITADEL ADVISORS LLC History Closed out 0 0 0.0% -10,844 -100.0% Q1 2026 May 15, 2026
UBS Group AG History Reduced 56 0 0.0% -1,892 -97.13% Q1 2026 May 05, 2026
BANK OF AMERICA CORP /DE/ History Closed out 0 0 -14 -100.0% Q1 2026 May 15, 2026
SBI Securities Co., Ltd. History No change 230 0 0 0.0% Q1 2026 Apr 27, 2026